Search Investor Updates

Investor Update provides you with up to date and informative articles about the investment climate in Australia.

Chinese delegation takes the pulse of Aussie medtech
26 May 2017
In a first for the Australian Government, Austrade and the Department of Industry, Innovation and Science (DIIS) worked with Australian companies and research groups to showcase investment opportuniti ...
Read article...
Mitsubishi Heavy Industries invests in Adelaide University research partnership
9 May 2017
Mitsubishi Heavy Industries (MHI), part of Japanese conglomerate Mitsubishi Group, has signed a collaborative research contract with the University of Adelaide.
Read article...
Board members announced for Northern Australia Cooperative Research Centre
22 Feb 2017
The Australian Government has announced the board members of the A$75 million Cooperative Research Centre (CRC) for Developing Northern Australia, which is responsible for attracting beneficial resear ...
Read article...
FUJIFILM and Australian stem cell company partner to commercialise treatment for graft-versus-host disease
20 Feb 2017
FUJIFILM Corporation of Japan and Cynata Therapeutics, an Australian stem cell and regenerative medicine company, have executed a license option agreement to develop and commercialise one of Cynata’s ...
Read article...
China–Australia consortium invests $1.7 billion in Australian healthcare expertise
25 Oct 2016
The Foreign Investment Review Board (FIRB) has approved the A$1.7 billion investment in GenesisCare by a consortium formed by Macquarie Capital and Hong Kong-based China Resources Group.
Read article...
More than A$1 billion invested in Australian research excellence
4 Oct 2016
The Australian Government has announced a new round of funding totalling A$283.5 million for nine Australian Research Council (ARC) Centres of Excellence. Cash and in-kind support worth A$761.4 millio ...
Read article...
China’s BGI invests in Australian genomics R&D
23 Aug 2016
Global genomics company BGI has reinforced its research and development (R&D) ties with Australia by opening a new Asia-Pacific headquarters in Brisbane.
Read article...
US pharmaceutical company invests in Australian R&D
27 Jul 2016
Provectus Biopharmaceuticals, a NYSE-listed developer of pharmaceutical products and therapies focusing on cancer, has established a new Australian subsidiary and office in Sydney.
Read article...
Australian medtech companies awarded BARDA funding
12 Jul 2016
A number of Australian wound-healing companies have recently gained funding from the US Biomedical Advanced Research and Development Authority (BARDA), proving the international competitiveness of the ...
Read article...
Recipients of Australian tropical medicine commercialisation grants announced
16 Jun 2016
Applications for ATMC grants program closed in March and the Australian organisations that have been offered grants have now been announced.
Read article...
Update on Australian Medical Research Advisory Board
28 Apr 2016
The Australian Government has announced appointments to the Australian Medical Research Advisory Board, set-up to advise how funds held in the Medical Research Future Fund should be deployed.
Read article...
New Nanoscience Hub at Sydney University
7 Apr 2016
The Australian Institute for Nanoscale Science and Technology at Sydney University will open a new Nanoscience Hub*on April 20.
Read article...
UK fintech launches point-of-payment rating system in Australia
31 Mar 2016
The UK fintech start-up, truRating – a point-of-payment rating system – has launched in Australia. The award-winning consumer ratings company has secured partnerships with some of Australia’s top-tier ...
Read article...
US pharmaceutical giant invests A$21 million in South Australia cancer drug facility
24 Mar 2016
Pfizer Australia, a subsidiary of the US biopharmaceutical giant, Pfizer Inc, is to expand operations in Adelaide, with an investment of A$21 million at its facility in Thebarton, in the city’s inner- ...
Read article...
Koreans invest in Australian biotech
23 Feb 2016
International investors have closed a A$13 million Series B financing round for Australian clinical stage medical company, Elastagen Pty Ltd.
Read article...
Australian medical technology company secures US$6 million from Global Health Investment Fund
17 Feb 2016
Atomo Diagnostics, a Sydney-based medical technology company, has secured US$6 million from the US-based Global Health Investment Fund (GHIF) to increase production of its rapid diagnostic test (RDT) ...
Read article...
Cancer Therapeutics CRC in multi-million dollar licensing deal
16 Feb 2016
In one of the largest preclinical deals in Australian biotech history, the Melbourne-based research company Cancer Therapeutics CRC (CTx) has a promising new cancer drug program licensed with MSD, kno ...
Read article...
A$250 million Biomedical Translation Fund to bridge gap between commercialisation and research
22 Jan 2016
The A$250 million Biomedical Translation Fund, announced by the Australian Government in late 2015, will invest in promising biomedical discoveries, help bridge the gap between research and commercial ...
Read article...
Pilot vaccine facility opened in Victoria
23 Dec 2015
Global pharmaceutical giant, GlaxoSmithKline (GSK), has opened a pilot vaccine facility in Boronia, Victoria, which uses ground-breaking new technology for the delivery of vaccines.
Read article...
Australia invests in the future
14 Dec 2015
Australia is investing in the future with a far-reaching A$1.1 billion National Innovation and Science Agenda announced by the Australian Prime Minister Malcolm Turnbull on 7 December 2015.
Read article...